Tapering infliximab dosages after temporary dose increase does not affect treatment survival in an established RA population
(2008)
Files
No attached file found for this publication.
Details
- Authors
- Affiliations
Citations
Vander Cruyssen, B., Durez, P., Westhovens, R., Van den Bosch, F., Mielants, H., De Clerck, L., Peretz, A., Malaise, M., Verbruggen, L., Dewulf, L., Vastesaeger, N., Geldhof, A., Noel, W., Boullart, L., & De Keyser, F. (2008). Tapering infliximab dosages after temporary dose increase does not affect treatment survival in an established RA population. Scandinavian Journal of Rheumatology, 37, 52. (Original work published 2008)